FI91864B - Analogiförfarande för framställning av en terapeutiskt användbar 3-piperidinyl-indazol - Google Patents

Analogiförfarande för framställning av en terapeutiskt användbar 3-piperidinyl-indazol Download PDF

Info

Publication number
FI91864B
FI91864B FI894125A FI894125A FI91864B FI 91864 B FI91864 B FI 91864B FI 894125 A FI894125 A FI 894125A FI 894125 A FI894125 A FI 894125A FI 91864 B FI91864 B FI 91864B
Authority
FI
Finland
Prior art keywords
formula
alk
methyl
benzyl
compounds
Prior art date
Application number
FI894125A
Other languages
English (en)
Finnish (fi)
Other versions
FI894125A0 (sv
FI91864C (sv
FI894125A (sv
Inventor
Ludo Edmond Josephine Kennis
Jan Vandenberk
Heertum Albertus Hendricus Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI894125A0 publication Critical patent/FI894125A0/sv
Publication of FI894125A publication Critical patent/FI894125A/sv
Application granted granted Critical
Publication of FI91864B publication Critical patent/FI91864B/sv
Publication of FI91864C publication Critical patent/FI91864C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
FI894125A 1988-09-02 1989-09-01 Analogiförfarande för framställning av en terapeutiskt användbar 3-piperidinyl-indazol FI91864C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23991588A 1988-09-02 1988-09-02
US23991588 1988-09-02

Publications (4)

Publication Number Publication Date
FI894125A0 FI894125A0 (sv) 1989-09-01
FI894125A FI894125A (sv) 1990-03-03
FI91864B true FI91864B (sv) 1994-05-13
FI91864C FI91864C (sv) 1994-08-25

Family

ID=22904291

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894125A FI91864C (sv) 1988-09-02 1989-09-01 Analogiförfarande för framställning av en terapeutiskt användbar 3-piperidinyl-indazol

Country Status (21)

Country Link
EP (1) EP0357134B1 (sv)
JP (1) JP2768992B2 (sv)
KR (1) KR0145705B1 (sv)
CN (1) CN1024346C (sv)
AT (1) ATE124410T1 (sv)
AU (1) AU614871B2 (sv)
CA (1) CA1331610C (sv)
DE (1) DE68923231T2 (sv)
DK (1) DK169547B1 (sv)
ES (1) ES2076201T3 (sv)
FI (1) FI91864C (sv)
GR (1) GR3017435T3 (sv)
HU (1) HU202232B (sv)
IE (1) IE66511B1 (sv)
IL (1) IL90879A0 (sv)
NO (1) NO176608C (sv)
NZ (1) NZ230367A (sv)
PH (1) PH26456A (sv)
PT (1) PT91613B (sv)
SU (1) SU1720489A3 (sv)
ZA (1) ZA896741B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
WO2004069828A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation ピペリジン化合物およびその医薬用途
EP3609883B1 (en) * 2017-04-11 2022-06-29 Sunshine Lake Pharma Co., Ltd. Fluorine-substituted indazole compounds and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
JPS58159480A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd 新規なフエニルピペラジン誘導体
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US4716161A (en) * 1984-04-17 1987-12-29 Mitsubishi Chemical Industries Limited Phenylpiperazine derivatives and their acid addition salts
CA1246074A (en) * 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
ATE61054T1 (de) * 1985-01-23 1991-03-15 Hoechst Roussel Pharma 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4711883A (en) * 1985-09-30 1987-12-08 Ortho Pharmaceutical Corporation Substituted 3-(4-phenyl-1-piperazinyl)alkylquinazolin-2,4-(1H,3H) diones, methods of preparation, compositions and method of use
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines

Also Published As

Publication number Publication date
ES2076201T3 (es) 1995-11-01
FI894125A0 (sv) 1989-09-01
FI91864C (sv) 1994-08-25
SU1720489A3 (ru) 1992-03-15
JPH02160778A (ja) 1990-06-20
IE892829L (en) 1990-03-02
PT91613B (pt) 1995-05-04
DK434789D0 (da) 1989-09-01
AU4084889A (en) 1990-03-08
PH26456A (en) 1992-07-27
ZA896741B (en) 1991-05-29
NZ230367A (en) 1991-03-26
NO893523D0 (no) 1989-09-01
HU202232B (en) 1991-02-28
KR900004721A (ko) 1990-04-12
DE68923231T2 (de) 1995-11-09
EP0357134B1 (en) 1995-06-28
IL90879A0 (en) 1990-02-09
PT91613A (pt) 1990-03-30
JP2768992B2 (ja) 1998-06-25
DK169547B1 (da) 1994-11-28
CN1040589A (zh) 1990-03-21
NO176608B (no) 1995-01-23
DK434789A (da) 1990-03-03
DE68923231D1 (de) 1995-08-03
CA1331610C (en) 1994-08-23
IE66511B1 (en) 1996-01-10
CN1024346C (zh) 1994-04-27
HUT51622A (en) 1990-05-28
KR0145705B1 (ko) 1998-08-17
AU614871B2 (en) 1991-09-12
GR3017435T3 (en) 1995-12-31
EP0357134A1 (en) 1990-03-07
NO176608C (no) 1995-05-03
ATE124410T1 (de) 1995-07-15
NO893523L (no) 1990-03-05
FI894125A (sv) 1990-03-03

Similar Documents

Publication Publication Date Title
US6087368A (en) Quinazolinone inhibitors of cGMP phosphodiesterase
EP0511865B1 (en) Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
FI71737B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(piperidinylalkyl)-4h-pyrido/1,2-a/ pyrimidin-4-on-derivat
US6326379B1 (en) Fused pyridine inhibitors of cGMP phosphodiesterase
US6576644B2 (en) Quinoline inhibitors of cGMP phosphodiesterase
US6316438B1 (en) Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
JP2019055986A (ja) 新規ピラゾール誘導体
JP2000119271A (ja) １ｈ―イミダゾピリジン誘導体
JP2007536374A (ja) ヒスタミンｈ３受容体リガンドとして有用なテトラヒドロナフチリヂン誘導体
US6077841A (en) 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
JP7090036B2 (ja) 新規な［１，２，３］トリアゾロ［４，５－ｄ］ピリミジン誘導体
FI94049C (sv) Förfarande för framställning av terapeutiskt användbara N-(3-hydroxi-4-piperidinyl)bensamider
US7314877B2 (en) Benzofuran derivative
IE66198B1 (en) Antipsychotic 3-piperazinylbenzazole derivatives
FI91864B (sv) Analogiförfarande för framställning av en terapeutiskt användbar 3-piperidinyl-indazol
US4529727A (en) Pyrimido[2,1-b][1,3]-thiazines
US6642244B2 (en) Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
US5196425A (en) Antihypertensive 3-piperidinyl-indazole derivatives
US5321028A (en) Antihypertensive 3-piperidinyl-indazole derivatives
CN111386270B (zh) 作为毒蕈碱m1受体正向别构调节剂的经取代氮杂环
US5158958A (en) Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
KR20240046742A (ko) 소분자 sting 길항제
JPH1072439A (ja) ピリジン誘導体

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: JANSSEN PHARMACEUTICA N.V.